Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: back to .21 does not bode well for confidence

Re: back to .21 does not bode well for confidence

posted on Jun 24, 2008 06:05AM

IMO what we'll see is a reexam certificate issued for 148 fairly soon....336 of course may take a lot longer...but here's our dilemma. When the 148 reexam is announced I believe we'll see a nice spike in the PPS, that is usually the first thing that should/could happen.

What is more important, IMO, is what kind of PR we get with it from PTSC and what "actions" if any, follow up right after that reexam. If we see no influx of licensing, because the 336 may be more important to the MMP than the 148 is, then we may very well see a drift backwards to levels we've seen lately. probably higher than it is right now but not much more, maybe 25- to the low 30's.

What effect that 148 reexam has on our revenue will be more important to the "street" than just a certficate will be.

RG and what he says and what actions he and they take will bhe the deciding factor on any momentum rise inthe PPS that will hold fast and retreat. JMHO

1
Jun 24, 2008 10:51AM
Share
New Message
Please login to post a reply